Verinetics

Verinetics is dedicated to making the medications used to treat opioid use disorder more accessible to more patients. The Verinetics DispenSecur™ system for medications management is intended as a tool to foster trust between patient and provider by improved monitoring and control over medications for opioid use disorder and other medications with potential for abuse, misuse or addiction. DispenSecur™ is a Class I Medical Device listed with the Food and Drug Administration for distribution in the United States and is intended for medical purposes to provide alerts and controlled patient access to medication based on dosing schedules predetermined by a healthcare provider. The device may be used with either liquid or solid dosage forms of one medication type. The device is not intended to manage multiple medications.

• Employees 7
• Founded 2009
• Total Funding $1287185